Servizo
Oncoloxía médica
Publicacións (55) Publicacións nas que participase algún/ha investigador/a
2017
-
A PAM50-based chemoendocrine score for hormone receptor-positive breast cancer with an intermediate risk of relapse
Clinical Cancer Research, Vol. 23, Núm. 12, pp. 3035-3044
-
A consensus statement on the gender perspective in lung cancer
Clinical and Translational Oncology, Vol. 19, Núm. 5, pp. 527-535
-
A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM)
Clinical and Translational Oncology, Vol. 19, Núm. 5, pp. 616-624
-
A high-resolution map of transcriptional repression
eLife, Vol. 6
-
A phase I study of the SRC kinase inhibitor dasatinib with trastuzumab and paclitaxel as first line therapy for patients with HER2-overexpressing advanced breast cancer. GEICAM/2010-04 study
Oncotarget, Vol. 8, Núm. 42, pp. 73144-73153
-
A randomized phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN)
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 28, Núm. 7, pp. 1517-1522
-
Anatomical variations of the greater palatine canal in cone-beam computed tomography
Surgical and Radiologic Anatomy, Vol. 39, Núm. 7, pp. 717-723
-
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: A multi-institution correlative biomarker study
Annals of Oncology, Vol. 28, Núm. 7, pp. 1-9
-
Anti-folate receptor-α IgE but not IgG recruits macrophages to attack tumors via TNFa/MCP-1 signaling
Cancer Research, Vol. 77, Núm. 5, pp. 1127-1141
-
Assessment of HER2 status in resected gastric cancer in European population
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 28, pp. iii15
-
Breast cancer chemoprevention: What and when?
Cancer and Chemotherapy Reviews, Vol. 12, Núm. 2, pp. 46-57
-
Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma
International Journal of Cancer, Vol. 140, Núm. 7, pp. 1551-1563
-
Clinical management of epidermal growth factor receptor mutation-positive non-small cell lung cancer patients after progression on previous epidermal growth factor receptor tyrosine kinase inhibitors: The necessity of repeated molecular analysis
Translational Lung Cancer Research, Vol. 6, pp. S21-S34
-
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain
Clinical and Translational Oncology, Vol. 19, Núm. 6, pp. 667-681
-
Development of psoriatic arthritis during nivolumab therapy for metastatic non-small cell lung cancer, clinical outcome analysis and review of the literature
Lung Cancer, Vol. 108, pp. 217-221
-
ERAP1 and HLA-C interaction in inflammatory bowel disease in the Spanish population
Innate Immunity, Vol. 23, Núm. 5, pp. 476-481
-
Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database
Clinical and Translational Oncology, Vol. 19, Núm. 12, pp. 1537-1542
-
Epistasis, physical capacity-related genes and exceptional longevity: FNDC5 gene interactions with candidate genes FOXOA3 and APOE
BMC Genomics, Vol. 18
-
Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions
Clinical and Translational Oncology, Vol. 19, Núm. 3, pp. 341-356
-
Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study
Clinical and Translational Oncology, Vol. 19, Núm. 1, pp. 91-104